Metastasis and MAPK Pathways

Int J Mol Sci. 2022 Mar 31;23(7):3847. doi: 10.3390/ijms23073847.

Abstract

Cancer is a leading cause of death worldwide. In many cases, the treatment of the disease is limited due to the metastasis of cells to distant locations of the body through the blood and lymphatic drainage. Most of the anticancer therapeutic options focus mainly on the inhibition of tumor cell growth or the induction of cell death, and do not consider the molecular basis of metastasis. The aim of this work is to provide a comprehensive review focusing on cancer metastasis and the mitogen-activated protein kinase (MAPK) pathway (ERK/JNK/P38 signaling) as a crucial modulator of this process.

Keywords: c-JUN N-terminal kinase (JNK); cancer; extracellular signal-regulated kinase (ERK); metastasis; mitogen-activated kinases (MAPKs).

Publication types

  • Review

MeSH terms

  • Humans
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • MAP Kinase Signaling System
  • Mitogen-Activated Protein Kinases* / metabolism
  • Neoplasms*
  • Phosphorylation
  • p38 Mitogen-Activated Protein Kinases / metabolism

Substances

  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases